- Home
- HOFT vs GNLX Comparison
HOFT vs GNLX Comparison
Compare HOFT & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOFT
- GNLX
- Stock Information
- Founded
- HOFT 1924
- GNLX 2001
- Country
- HOFT United States
- GNLX United States
- Employees
- HOFT N/A
- GNLX N/A
- Industry
- HOFT Home Furnishings
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- HOFT Consumer Discretionary
- GNLX Health Care
- Exchange
- HOFT Nasdaq
- GNLX Nasdaq
- Market Cap
- HOFT 119.9M
- GNLX 96.6M
- IPO Year
- HOFT 1999
- GNLX 2023
- Fundamental
- Price
- HOFT $11.32
- GNLX $2.87
- Analyst Decision
- HOFT
- GNLX Strong Buy
- Analyst Count
- HOFT 0
- GNLX 4
- Target Price
- HOFT N/A
- GNLX $17.75
- AVG Volume (30 Days)
- HOFT 186.5K
- GNLX 151.1K
- Earning Date
- HOFT 06-12-2025
- GNLX 08-13-2025
- Dividend Yield
- HOFT 8.43%
- GNLX N/A
- EPS Growth
- HOFT N/A
- GNLX N/A
- EPS
- HOFT N/A
- GNLX N/A
- Revenue
- HOFT $389,210,000.00
- GNLX N/A
- Revenue This Year
- HOFT $1.35
- GNLX N/A
- Revenue Next Year
- HOFT $10.05
- GNLX N/A
- P/E Ratio
- HOFT N/A
- GNLX N/A
- Revenue Growth
- HOFT N/A
- GNLX N/A
- 52 Week Low
- HOFT $7.34
- GNLX $1.60
- 52 Week High
- HOFT $19.79
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- HOFT 62.89
- GNLX 52.48
- Support Level
- HOFT $9.97
- GNLX $2.75
- Resistance Level
- HOFT $12.09
- GNLX $3.17
- Average True Range (ATR)
- HOFT 0.84
- GNLX 0.25
- MACD
- HOFT 0.09
- GNLX 0.01
- Stochastic Oscillator
- HOFT 81.85
- GNLX 44.74
About HOFT Hooker Furnishings Corporation
Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.